PDF下载 ( 227 KB)
An excerpt of AGA clinical practice update:Surgical risk assessment and perioperative management in cirrhosis (2018)
-
摘要:
<正>尽管由病毒性肝炎和慢性非酒精性脂肪性肝炎(NASH)所引起的慢性肝病发病率在世界范围内增加,但得益于医疗与外科技术的进步,患者生存期延长,然而可能会罹患更严重的疾病。肝纤维化患者在长期生存时有罹患肝癌、肥胖相关疾病的风险,除肝移植外也面临其他急诊手术或限期手术的可能。早期研究显示肝纤维化患者标准手术治疗后围术期病死率高达
-
Key words:
- liver cirrhosis /
- surgical procedures, operative /
- United States /
- practice guideline
-
[1] NORTHUP PG, WANAMAKER RC, LEE VD, et al. Model forend-stage liver disease (MELD) predicts nontransplant sur-gical mortality in patients with cirrhosis[J]. Ann Surg, 2005, 242 (2) :244-251. [2] TEH SH, NAGORNEY DM, STEVENS SR, et al. Risk factorsfor mortality after surgery in patients with cirrhosis[J]. Gastro-enterology, 2007, 132 (4) :1261-1269. [3] BEFELER AS, PALMER DE, HOFFMAN M, et al. The safety ofintra-abdominal surgery in patients with cirrhosis:Model forend-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome[J]. Arch Surg, 2005, 140 (7) :650-654, discussion 655. [4] BRUIX J, CASTELLS A, BOSCH J, et al. Surgical resection ofhepatocellular carcinoma in cirrhotic patients:Prognostic valueof preoperative portal pressure[J]. Gastroenterology, 1996, 111 (4) :1018-1022. [5] TEH SH, CHRISTEIN J, DONOHUE J, et al. Hepatic resectionof hepatocellular carcinoma in patients with cirrhosis:Model ofend-stage liver disease (MELD) score predicts perioperativemortality[J]. J Gastrointest Surg, 2005, 9 (9) :1207-1215, discussion 1215. [6] LLOP E, BERZIGOTTI A, REIG M, et al. Assessment of portalhypertension by transient elastography in patients with com-pensated cirrhosis and potentially resectable liver tumors[J].J Hepatol, 2012, 56 (1) :103-108. [7] BINGENER J, COX D, MICHALEK J, et al. Can the MELD scorepredict perioperative morbidity for patients with liver cirrhosis un-dergoing laparoscopic cholecystectomy?[J]. Am Surg, 2008, 74 (2) :156-159. [8] FERNANDES NF, SCHWESINGER WH, HILSENBECK SG, etal. Laparoscopic cholecystectomy and cirrhosis:A case-control study of outcomes[J]. Liver Transpl, 2000, 6 (3) :340-344. [9] TERRAULT N, CHEN YC, IZUMI N, et al. Avatrombopag be-fore procedures reduces need for platelet transfusion in pa-tients with chronic liver disease and thrombocytopenia[J].Gastroenterology, 2018, 155 (3) :705-718. [10] NEEFF H, MARIASKIN D, SPANGENBERG HC, et al. Periop-erative mortality after non-hepatic general surgery in patientswith liver cirrhosis:An analysis of 138 operations in the 2000susing child and MELD scores[J]. J Gastrointest Surg, 2011, 15 (1) :1-11. [11] SUMAN A, BARNES DS, ZEIN NN, et al. Predicting outcomeafter cardiac surgery in patients with cirrhosis:A comparisonof Child-Pugh and MELD scores[J]. Clin Gastroenterol Hep-atol, 2004, 2 (8) :719-723. [12] THIELMANN M, MECHMET A, NEUHAUSER M, et al. Riskprediction and outcomes in patients with liver cirrhosis under-going open-heart surgery[J]. Eur J Cardiothorac Surg, 2010, 38 (5) :592-599. [13] SHIMIZU H, PHUONG V, MAIA M, et al. Bariatric surgery inpatients with liver cirrhosis[J]. Surg Obes Relat Dis, 2013, 9 (1) :1-6. [14] IWASAKI A, SHIRAKUSA T, OKABAYASHI K, et al. Lung cancersurgery in patients with liver cirrhosis[J]. Ann Thorac Surg, 2006, 82 (3) :1027-1032. [15] LEE JH, YU CS, LEE JL, et al. Factors affecting the postoper-ative morbidity and survival of patients with liver cirrhosis fol-lowing colorectal cancer surgery[J]. Int J Colorectal Dis, 2017, 32 (4) :521-530. [16] WIKKELSO A, WETTERSLEV J, MOLLER AM, et al. Throm-boelastography (teg) or thromboelastometry (rotem) to moni-tor haemostatic treatment versus usual care in adults or chil-dren with bleeding[J]. Cochrane Database Syst Rev, 2016, (8) :CD007871. [17] LIAO JC, CHEN WJ, CHEN LH, et al. Complications associat-ed with instrumented lumbar surgery in patients with liver cir-rhosis:A matched cohort analysis[J]. Spine J, 2013, 13 (8) :908-913. [18] CHEN CC, HSU PW, LEE ST, et al. Brain surgery in patients withliver cirrhosis[J]. J Neurosurg, 2012, 117 (2) :348-353. [19] KOTB HI, FOUAD IA, FARES KM, et al. Pharmacokinetics oforal tramadol in patients with liver cancer[J]. J Opioid Man-ag, 2008, 4 (2) :99-104. [20] BENSON GD. Acetaminophen in chronic liver disease[J].Clin Pharmacol Ther, 1983, 33 (1) :95-101. -
本文二维码
计量
- 文章访问数: 207
- HTML全文浏览量: 12
- PDF下载量: 140
- 被引次数: 0
下载:
